26 May 2013
Keywords: three-month, delay, prasugrel, nda, japanese, drugmaker, daiichi
Article | 30 June 2008
Japanese drugmaker Daiichi Sankyo and US pharmaceutical major Eli Lilly say that the Food and Drug Administration has extended the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
24 May 2013
© 2013 thepharmaletter.com